Fibromyalgia is a chronic condition that causes widespread pain all over the body, fatigue and poor sleep, and it often also causes problems with mood, memory and concentration. It affects about 2% of ...
Depression relief was the primary driver of disease improvement among patients with fibromyalgia and prominent anxiety and depression symptoms.
LOS ANGELES (KABC) -- Fibromyalgia and chronic fatigue syndrome are two mysterious and debilitating conditions - and they're often confused with each other. Tiredness, pain, trouble concentrating and ...
"Fibromyalgia is a common condition affecting 3.7 million Americans. Fibromyalgia causes scattered pain, lack of energy, poor sleep and myriad other signs and symptoms. Because symptoms of many ...
Living with fibromyalgia means navigating a complex web of widespread pain, profound fatigue, and cognitive challenges that fluctuate in intensity from day to day. For the estimated 4% of the ...
A smartphone app that delivers acceptance and commitment therapy (ACT), a type of cognitive behavioral therapy, improves overall well-being and reduces the severity of pain, fatigue, sleep issues, and ...
Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some patients to seek pain relief from substance use.
Please provide your email address to receive an email when new articles are posted on . Quality of life, depression and anxiety were among the symptoms that improved after using the device. The device ...
Both exposure-based cognitive behavioral therapy (Exp- CBT) and traditional CBT may reduce symptoms of fibromyalgia. The corresponding study was published in Pain. Fibromyalgia is a chronic pain ...
PITTSBURGH--(BUSINESS WIRE)--Swing Therapeutics announced that Stanza, its digital therapeutic for treatment of fibromyalgia symptoms, has received a positive coverage decision from Highmark Health.
April 1, 2010 — Accumulating 30 minutes a day of "lifestyle" physical activity, by walking more, using the stairs, or gardening, for example, led to significant improvements in perceived physical ...
WOBURN, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) for Quell as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results